Related Experiment Videos
Patterns of psychotropic medication use in very young children with attention-deficit hyperactivity disorder
Marsha D Rappley1, Ihuoma U Eneli, Patricia B Mullan
1Department of Pediatrics and Human Development, College of Human Medicine, Michigan State University, East Lansing, MI 48824, USA. rappley@msu.edu
Insights
Psychotropic medication use in children under 4 with ADHD is common but often idiosyncratic. This highlights a critical need for better guidance on psychopharmacological treatment for young children.
Area of Science:
- Pediatric Psychopharmacology
- Child Psychiatry
- Developmental Neuroscience
Background:
- Increasing use of psychotropic medications in very young children.
- Attention-deficit hyperactivity disorder (ADHD) is a common diagnosis in early childhood.
Purpose of the Study:
- To describe patterns of psychotropic medication use in children aged 3 years and younger with ADHD.
- To identify concerns regarding the administration and monitoring of these medications in this age group.
Main Methods:
- Retrospective analysis of 223 children diagnosed with ADHD.
- Examination of medication types, duration, and monitoring frequency.
- Analysis of risk factors for psychotropic medication prescription.
Main Results:
- Over half (n=127) of children with ADHD received psychotropic medications idiosyncratically.
- Nearly half of medicated children lacked monitoring every 3 months, despite long-term use (≥6 months).
- Comorbid mental health and chronic health conditions increased risk for medication use.
Conclusions:
- Current psychotropic medication use patterns in very young children with ADHD are concerning.
- There is a significant need for evidence-based guidelines for psychopharmacological treatment in this population.
- Improved monitoring protocols are essential for safe and effective treatment.
Abstract:
Psychotropic medications are increasingly used for very young children. Patterns of use in a well-described group of children 3 years and younger with a diagnostic label of attention-deficit hyperactivity disorder (ADHD) reveal both reasons to use such medications and concerns about how these medications are used. Of 223 children with ADHD, more than half (n = 127) received psychotropic medications in an idiosyncratic manner, both in the specific medication and in use over time. Almost half of the children who were medicated did not have opportunities for monitoring as often as every 3 months, despite the fact that more than half received psychotropic medications for 6 months or longer. Children with comorbid mental health conditions and chronic health conditions were at greater risk for receiving psychotropic medications. These patterns of use demonstrate a compelling need for guidance in psychopharmacological treatment of very young children.